ConductScience.org, home

Trial · NCT06926868

Registered outcomes26

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
SecondaryTime to subsequent treatment (TTST) per InvestigatorApproximately up to 47 months from first participant randomization in Phase 3Defined as time from randomization to the start of subsequent therapy or death
SecondaryProgression-free survival after next line of treatment (PFS2)Approximately up to 47 months from first participant randomization in Phase 3Defined as the time from randomization to the date of investigator-defined documented disease progression after next line of treatment or death due to any cause, whichever comes first
SecondaryChange from baseline in European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)Approximately up to 47 months from first participant randomization in Phase 3
SecondaryChange from baseline in EORTC Breast Cancer-specific Quality of Life Questionnaire (QLQ-BR23)Approximately up to 47 months from first participant randomization in Phase 3
SecondaryFunctional Assessment of Chronic Illness Therapy item GP5 (FACIT GP5) scoreApproximately up to 47 months from first participant randomization in Phase 3
SecondaryChange from baseline in European Quality of Life 5 Dimensions 5 Levels (EQ-5D-5L)Approximately up to 47 months from first participant randomization in Phase 3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06926868/registered?page=2